Aker BioMarine AS reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was USD 49.2 million compared to USD 47.2 million a year ago. Net income was USD 0.7 million compared to net loss of USD 2.4 million a year ago. Basic loss per share from continuing operations was USD 0.03. Diluted loss per share from continuing operations was USD 0.03.
For the six months, sales was USD 97.7 million compared to USD 94.6 million a year ago. Net loss was USD 11.2 million compared to USD 20 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.06 a year ago. Diluted loss per share from continuing operations was USD 0.08 compared to USD 0.06 a year ago.